These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15243303)

  • 41. Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylurea.
    Triplitt C; Glass L; Miyazaki Y; Wajcberg E; Gastaldelli A; De Filippis E; Cersosimo E; DeFronzo RA
    Diabetes Care; 2006 Nov; 29(11):2371-7. PubMed ID: 17065670
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rosiglitazone: safety and efficacy in combination with insulin in poorly controlled type 2 diabetes mellitus patients treated with insulin alone.
    Garg R; Gopal J; Jones GR
    J Diabetes Complications; 2007; 21(1):1-6. PubMed ID: 17189867
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pioglitazone metabolic effect in metformin-intolerant obese patients treated with sibutramine.
    Derosa G; Mereu R; Salvadeo SA; D'Angelo A; Ciccarelli L; Piccinni MN; Ferrari I; Gravina A; Maffioli P; Cicero AF
    Intern Med; 2009; 48(5):265-71. PubMed ID: 19252346
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.
    Fonseca V; Rosenstock J; Patwardhan R; Salzman A
    JAMA; 2000 Apr; 283(13):1695-702. PubMed ID: 10755495
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of rosiglitazone on glycaemic control, insulin levels and blood pressure values in patients with type 2 diabetes.
    Kulenović I
    Med Arh; 2006; 60(3):179-81. PubMed ID: 16719233
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus.
    Rosenblatt S; Miskin B; Glazer NB; Prince MJ; Robertson KE;
    Coron Artery Dis; 2001 Aug; 12(5):413-23. PubMed ID: 11491207
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glycemic control with glyburide/metformin tablets in combination with rosiglitazone in patients with type 2 diabetes: a randomized, double-blind trial.
    Dailey GE; Noor MA; Park JS; Bruce S; Fiedorek FT
    Am J Med; 2004 Feb; 116(4):223-9. PubMed ID: 14969649
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of rosiglitazone on beta-cell function, insulin resistance, and adiponectin concentrations: results from a double-blind oral combination study with glimepiride.
    Pfützner A; Schöndorf T; Seidel D; Winkler K; Matthaei S; Hamann A; Forst T
    Metabolism; 2006 Jan; 55(1):20-5. PubMed ID: 16324915
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control.
    Pistrosch F; Passauer J; Fischer S; Fuecker K; Hanefeld M; Gross P
    Diabetes Care; 2004 Feb; 27(2):484-90. PubMed ID: 14747233
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rosiglitazone increases LDL particle size and buoyancy and decreases C-reactive protein in patients with type 2 diabetes on statin therapy.
    Yu D; Murdoch SJ; Parikh SJ; Marcovina SM; Cobitz A; Chen H; Brunzell JD
    Diab Vasc Dis Res; 2006 Dec; 3(3):189-96. PubMed ID: 17160915
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential effect of glimepiride and rosiglitazone on metabolic control of type 2 diabetic patients treated with metformin: a randomized, double-blind, clinical trial.
    Derosa G; Gaddi AV; Piccinni MN; Salvadeo S; Ciccarelli L; Fogari E; Ghelfi M; Ferrari I; Cicero AF
    Diabetes Obes Metab; 2006 Mar; 8(2):197-205. PubMed ID: 16448524
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Roberts VL; Stewart J; Issa M; Lake B; Melis R
    Clin Ther; 2005 Oct; 27(10):1535-47. PubMed ID: 16330290
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Beneficial effects of triple drug combination of pioglitazone with glibenclamide and metformin in type 2 diabetes mellitus patients on insulin therapy.
    Panikar V; Chandalia HB; Joshi SR; Fafadia A; Santvana C
    J Assoc Physicians India; 2003 Nov; 51():1061-4. PubMed ID: 15260389
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of simvastatin and atorvastatin administration on insulin resistance and respiratory quotient in aged dyslipidemic non-insulin dependent diabetic patients.
    Paolisso G; Barbagallo M; Petrella G; Ragno E; Barbieri M; Giordano M; Varricchio M
    Atherosclerosis; 2000 May; 150(1):121-7. PubMed ID: 10781642
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antihypertensive efficacy of manidipine and enalapril in hypertensive diabetic patients.
    Mancia G; Omboni S; Agabiti-Rosei E; Casati R; Fogari R; Leonetti G; Montemurro G; Nami R; Pessina AC; Pirrelli A; Zanchetti A
    J Cardiovasc Pharmacol; 2000 Jun; 35(6):926-31. PubMed ID: 10836728
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The combined effect of triple therapy with rosiglitazone, metformin, and insulin aspart in type 2 diabetic patients.
    Poulsen MK; Henriksen JE; Hother-Nielsen O; Beck-Nielsen H
    Diabetes Care; 2003 Dec; 26(12):3273-9. PubMed ID: 14633813
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Beneficial effect of troglitazone, an insulin-sensitizing antidiabetic agent, on coronary circulation in patients with non-insulin-dependent diabetes mellitus.
    Sekiya M; Suzuki J; Watanabe K; Funada J; Otani T; Akutsu H
    Jpn Circ J; 2001 Jun; 65(6):487-90. PubMed ID: 11407727
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.
    Kahn SE; Haffner SM; Heise MA; Herman WH; Holman RR; Jones NP; Kravitz BG; Lachin JM; O'Neill MC; Zinman B; Viberti G;
    N Engl J Med; 2006 Dec; 355(23):2427-43. PubMed ID: 17145742
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of glitazones in the treatment of diabetes and/or hyperlipidaemia: glycaemic control and plasma lipid levels.
    Vergès B
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():15-8. PubMed ID: 18001314
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of fixed-dose rosiglitazone/metformin combination therapy with sulphonylurea plus metformin in overweight individuals with Type 2 diabetes inadequately controlled on metformin alone.
    Hamann A; Garcia-Puig J; Paul G; Donaldson J; Stewart M
    Exp Clin Endocrinol Diabetes; 2008 Jan; 116(1):6-13. PubMed ID: 18095238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.